Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 10, Pages 2874
Publisher
MDPI AG
Online
2018-09-21
DOI
10.3390/ijms19102874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
- (2018) Bodo Haas et al. Cancer Cell International
- Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
- (2018) William C. Stafford et al. Science Translational Medicine
- Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis
- (2018) Guo-Xin Hou et al. Cell Death & Disease
- Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma
- (2018) Jing Hu et al. MOLECULAR CANCER THERAPEUTICS
- Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
- (2017) Hua-fu Zhao et al. Molecular Cancer
- Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis
- (2017) Kishore Gollapalli et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Targeting the Thioredoxin System for Cancer Therapy
- (2017) Junmin Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death
- (2017) Karoline Johanna Habermann et al. Cell Death & Disease
- A novel indication of thioredoxin-interacting protein as a tumor suppressor gene in malignant glioma
- (2017) Pengxing Zhang et al. Oncology Letters
- Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
- (2017) Hui Wang et al. Oncotarget
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition
- (2016) Prahlad V. Raninga et al. CELL CYCLE
- Expression of the thioredoxin system in an in vivo -like cancer cell environment upon auranofin treatment
- (2016) Maneet Bhatia et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin
- (2016) Deepu Oommen et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013
- (2016) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism
- (2016) Samuel N. Rodman et al. RADIATION RESEARCH
- Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer
- (2016) Tae Woo Kim et al. Oncotarget
- Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma
- (2016) Prahlad V. Raninga et al. Redox Biology
- The thioredoxin system in breast cancer cell invasion and migration
- (2016) Maneet Bhatia et al. Redox Biology
- Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
- (2015) Hongbiao Huang et al. Oncotarget
- Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
- (2015) Prahlad V. Raninga et al. Oncotarget
- Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells
- (2015) Hongyu Li et al. Oncotarget
- Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia
- (2014) W. Fiskus et al. CANCER RESEARCH
- Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma
- (2014) Estefanía Carrasco-García et al. Cells
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started